Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
| Autor: | Cremolini, C. 1, 2, Loupakis, F. 1, 2, Antoniotti, C. 1, 2, Lonardi, S. 3, Masi, G. 1, 2, Salvatore, L. 1, 2, Cortesi, E. 4, Tomasello, G. 5, Spadi, R. 6, Zaniboni, A. 7, Tonini, G. 8, Barone, C. 9, Vitello, S. 10, Longarini, R. 11, Bonetti, A. 12, D'Amico, M. 13, Di Donato, S. 14, Granetto, C. 15, Boni, L. 16, Falcone, A. 1, 2, * |
|---|---|
| Zdroj: | In Annals of Oncology June 2015 26(6):1188-1194 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|